Literature DB >> 16972754

siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.

Ken Ohnishi1, Zorica Scuric, Robert H Schiestl, Noritomo Okamoto, Akihisa Takahashi, Takeo Ohnishi.   

Abstract

NBS1 is essential for the repair of radiation-induced DNA double-strand breaks (DSBs) in yeast and higher vertebrate cells. In this study, we examined whether suppressed NBS1 expression by small interference RNA (siRNA) could enhance radiation sensitivity in cancer cells with different TP53 status. We used human non-small cell lung cancer cells differing in TP53 gene status (H1299/wtp53 cells bearing wild-type TP53 or H1299/mp53 cells bearing mutant TP53). A DNA cassette expressing siRNA targeted for the NBS1 gene was transfected into those cell lines, and radiation sensitivity was examined with a colony-forming assay. Cellular levels of NBS1 and other proteins were analyzed using Western blotting. We found that the radiation sensitivity of H1299/wtp53 and H1299/mp53 cells was enhanced by transfection of the DNA cassette. In the NBS1-siRNA-transfected cells, we observed decreased constitutive expression of NBS1 protein and decreased radiation-induced accumulation of phosphorylated NBS1 protein. In addition, radiation-induced expression of the transcription factor NF-kappaB (NFKB) and XIAP (X-chromosome-linked inhibitor of apoptosis protein) was suppressed by NBS1-siRNA. Enhanced X-ray sensitivity after NBS1-siRNA transfection was achieved in TP53 wild-type cells and sensitivity was even more pronounced in TP53 mutant cells. The transfection of siRNA targeted for XIAP also enhanced X-ray sensitivity even more for TP53 mutant cells compared to TP53 wild-type cells. Our data suggest that the sensitization to radiation results from NBS1-siRNA-mediated suppression of DNA repair and/ or X-ray-induced cell survival signaling pathways through NFKB and XIAP. siRNA targeting appears to be a novel radiation-sensitizing agent, particularly in human TP53 mutant cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972754     DOI: 10.1667/RR3606.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  24 in total

1.  Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.

Authors:  Yao Dai; Meilan Liu; Wenhua Tang; Jeffrey DeSano; Ezra Burstein; Mary Davis; Kenneth Pienta; Theodore Lawrence; Liang Xu
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

2.  Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein.

Authors:  Qin Qin; Yun Zuo; Xi Yang; Jing Lu; Liangliang Zhan; Liping Xu; Chi Zhang; Hongcheng Zhu; Jia Liu; Zheming Liu; Guangzhou Tao; Shengbin Dai; Xizhi Zhang; Jianxin Ma; Jing Cai; Xinchen Sun
Journal:  Tumour Biol       Date:  2013-10-30

3.  Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

Authors:  Xiaohua Ni; Yonggang Zhang; Judit Ribas; Wasim H Chowdhury; Mark Castanares; Zhewei Zhang; Marikki Laiho; Theodore L DeWeese; Shawn E Lupold
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

4.  The effects of antioxidants on gene expression following gamma-radiation (GR) and proton radiation (PR) in mice in vivo.

Authors:  Niklas Finnberg; Chris Wambi; Ann R Kennedy; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

5.  Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.

Authors:  Lori Rink; Artur Slupianek; Tomasz Stoklosa; Margaret Nieborowska-Skorska; Katarzyna Urbanska; Ilona Seferynska; Krzysztof Reiss; Tomasz Skorski
Journal:  Blood       Date:  2007-04-12       Impact factor: 22.113

Review 6.  Apoptosis Detection Methods in Diagnosis of Cancer and Their Potential Role in Treatment: Advantages and Disadvantages: a Review.

Authors:  Amir Khodavirdipour; Motahareh Piri; Sarvin Jabbari; Shiva Keshavarzi; Reza Safaralizadeh; Mohammad Yousef Alikhani
Journal:  J Gastrointest Cancer       Date:  2021-01-04

7.  Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines.

Authors:  Tzu-Pin Lu; Liang-Chuan Lai; Be-I Lin; Li-Han Chen; Tzu-Hung Hsiao; Howard L Liber; John A Cook; James B Mitchell; Mong-Hsun Tsai; Eric Y Chuang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

8.  Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.

Authors:  Yao Dai; Theodore S Lawrence; Liang Xu
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

9.  Therapeutic strategies for head and neck cancer based on p53 status.

Authors:  Ichiro Ota; Noritomo Okamoto; Katsunari Yane; Akihisa Takahashi; Takashi Masui; Hiroshi Hosoi; Takeo Ohnishi
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

10.  Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex.

Authors:  Kwang Seok Kim; Jong-Ik Heo; Kyu Jin Choi; Sangwoo Bae
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.